Basic Information
| RNALocate ID: | RLID:11000605 |
| RNA Symbol: | hsa-let-7c-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-let-7c |
| RNA ID: | miRBase:MIMAT0000064 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25184951 |
| Tissue/Cell Line: | Human esophageal cancer cell line (EC9706) |
| Method: | Next-generation RNA sequencing |
| Description: | All known miRNAs in exosomes were detected at lower levels compared with their corresponding cells, whereas several novel miRNAs in exosomes were detected at higher levels compared with their corresponding cells. Data are collected from Table 3. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001208 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001209 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001210 | Cytoplasm | HeLa cells | 22058130 |
| RLID:01001211 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001212 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001213 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001214 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001215 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001216 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001217 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:01001218 | Nucleus | HeLa cells | 22058130 |
| RLID:11000594 | Exosome | Saliva | 19627513 |
| RLID:11000595 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11000596 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000597 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11000598 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000599 | Exosome | Breast milk | 22211110 |
| RLID:11000600 | Exosome | Malignant melanoma cell line (A375) | 23056502 |
| RLID:11000601 | Exosome | Saliva | 23302638 |
| RLID:11000602 | Exosome | Brain tissue | 23382797 |
| RLID:11000603 | Exosome | Plasma | 23663360 |
| RLID:11000604 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000606 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000607 | Microvesicle | Plasma | 23077538 |
| RLID:11000608 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000609 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11000610 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000003 | Exosome | Blood|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Saliva|Seminal fluid | |
| RLID-D:11000263 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7c-5p | Diffuse large b cell lymphoma | MNDR-E-MI-00967 |
| MNDR | hsa-let-7c-5p | Splenic marginal zone lymphoma | MNDR-E-MI-00968 |
| MNDR | hsa-let-7c-5p | Oral squamous cell carcinoma | MNDR-E-MI-00969 |
| MNDR | hsa-let-7c-5p | Large cell neuroendocrine cancer | MNDR-E-MI-00970 |
| MNDR | hsa-let-7c-5p | B cell lymphoma of malt type | MNDR-E-MI-00971 |
| MNDR | hsa-let-7c-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-00972 |
| MNDR | hsa-let-7c-5p | Ovarian clear cell carcinoma | MNDR-E-MI-00973 |
| MNDR | hsa-let-7c-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-00974 |
| MNDR | hsa-let-7c-5p | Lymphoma non-hodgkin | MNDR-E-MI-00975 |
| MNDR | hsa-let-7c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-00976 |
| MNDR | hsa-let-7c-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-00977 |
| MNDR | hsa-let-7c-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-00978 |
| MNDR | hsa-let-7c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-00979 |
| MNDR | hsa-let-7c-5p | Her2-receptor positive breast cancer | MNDR-E-MI-00980 |
| MNDR | hsa-let-7c-5p | Prostate cancer | MNDR-E-MI-00981 |
| MNDR | hsa-let-7c-5p | Gastric cancer | MNDR-E-MI-00982 |
| MNDR | hsa-let-7c-5p | Gastric lymphoma | MNDR-E-MI-00983 |
| MNDR | hsa-let-7c-5p | Alzheimer disease | MNDR-E-MI-00984 |
| MNDR | hsa-let-7c-5p | Bladder cancer | MNDR-E-MI-00985 |
| MNDR | hsa-let-7c-5p | Dysautonomia familial | MNDR-E-MI-00986 |
| MNDR | hsa-let-7c-5p | Head and neck cancer | MNDR-E-MI-00987 |
| MNDR | hsa-let-7c-5p | Leukemia | MNDR-E-MI-00988 |
| MNDR | hsa-let-7c-5p | Cardiovascular disease | MNDR-E-MI-00989 |
| MNDR | hsa-let-7c-5p | Carotid stenosis | MNDR-E-MI-00990 |
| MNDR | hsa-let-7c-5p | Lung cancer | MNDR-E-MI-00991 |
| MNDR | hsa-let-7c-5p | Metabolic syndrome x | MNDR-E-MI-00992 |
| MNDR | hsa-let-7c-5p | Parkinson disease | MNDR-E-MI-00993 |
| MNDR | hsa-let-7c-5p | Breast cancer | MNDR-E-MI-00994 |
| MNDR | hsa-let-7c-5p | Neuroendocrine neoplasia | MNDR-E-MI-00995 |
| MNDR | hsa-let-7c-5p | Pancreatic cancer | MNDR-E-MI-00996 |
| MNDR | hsa-let-7c-5p | Melanoma | MNDR-E-MI-00997 |
| MNDR | hsa-let-7c-5p | Rectum adenocarcinoma | MNDR-E-MI-00998 |
| MNDR | hsa-let-7c-5p | Nephroblastoma | MNDR-E-MI-00999 |
| MNDR | hsa-let-7c-5p | Colon cancer | MNDR-E-MI-01000 |
| MNDR | hsa-let-7c-5p | Colon adenocarcinoma | MNDR-E-MI-01001 |
| MNDR | hsa-let-7c-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-01002 |
| MNDR | hsa-let-7c-5p | Familial ovarian cancer | MNDR-E-MI-01003 |
| MNDR | hsa-let-7c-5p | Prostate adenocarcinoma | MNDR-E-MI-01004 |
| MNDR | hsa-let-7c-5p | Carcinoma ductal breast | MNDR-E-MI-01005 |
| MNDR | hsa-let-7c-5p | Glioma | MNDR-E-MI-01006 |
| MNDR | hsa-let-7c-5p | Chordoma | MNDR-E-MI-01007 |
| MNDR | hsa-let-7c-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-01008 |
| MNDR | hsa-let-7c-5p | Osteosarcoma | MNDR-E-MI-01009 |
| MNDR | hsa-let-7c-5p | Middle cerebral artery infarction | MNDR-E-MI-01010 |
| MNDR | hsa-let-7c-5p | Hepatocellular cancer | MNDR-E-MI-01011 |
| MNDR | hsa-let-7c-5p | Uterine cancer | MNDR-E-MI-01012 |
| MNDR | hsa-let-7c-5p | Cervical adenocarcinoma | MNDR-E-MI-01013 |
| MNDR | hsa-let-7c-5p | Gastric adenocarcinoma | MNDR-E-MI-01014 |
| MNDR | hsa-let-7c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-01015 |
| MNDR | hsa-let-7c-5p | Lung squamous cell carcinoma | MNDR-E-MI-01016 |
| MNDR | hsa-let-7c-5p | Lung adenocarcinoma | MNDR-E-MI-01017 |
| MNDR | hsa-let-7c-5p | Thyroid carcinoma | MNDR-E-MI-01018 |
| MNDR | hsa-let-7c-5p | Tuberculosis | MNDR-E-MI-01019 |
| MNDR | hsa-let-7c-5p | Ovarian carcinoma | MNDR-E-MI-01020 |
| MNDR | hsa-let-7c-5p | Bladder urothelial carcinoma | MNDR-E-MI-01021 |
| MNDR | hsa-let-7c-5p | Pancreatic adenocarcinoma | MNDR-E-MI-01022 |
| MNDR | hsa-let-7c-5p | Myasthenia gravis | MNDR-E-MI-01023 |
| MNDR | hsa-let-7c-5p | Carcinoma renal cell | MNDR-E-MI-01024 |
| MNDR | hsa-let-7c-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-01025 |
| MNDR | hsa-let-7c-5p | Clear cell renal cell carcinoma | MNDR-E-MI-01026 |
| MNDR | hsa-let-7c-5p | Large cell carcinoma | MNDR-E-MI-01027 |
| MNDR | hsa-let-7c-5p | Biliary tract cancer | MNDR-E-MI-01028 |
| MNDR | hsa-let-7c-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-01029 |
| MNDR | hsa-let-7c-5p | Cholangiocarcinoma | MNDR-E-MI-01030 |
| MNDR | hsa-let-7c-5p | Esophageal cancer | MNDR-E-MI-01031 |
| MNDR | hsa-let-7c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-01032 |
| MNDR | hsa-let-7c-5p | Adenoma | MNDR-E-MI-01033 |
| MNDR | hsa-let-7c-5p | Breast invasive carcinoma | MNDR-E-MI-01034 |
| MNDR | hsa-let-7c-5p | Early hepatocellular carcinoma | MNDR-E-MI-01035 |
| MNDR | hsa-let-7c-5p | Familiar ovarian carcinoma | MNDR-E-MI-01036 |
| MNDR | hsa-let-7c-5p | B-cell lymphoma | MNDR-E-MI-01037 |
| MNDR | hsa-let-7c-5p | Rheumatoid arthritis | MNDR-E-MI-01038 |
| MNDR | hsa-let-7c-5p | T-cell leukemia | MNDR-E-MI-01039 |
| MNDR | hsa-let-7c-5p | Retinoblastoma | MNDR-E-MI-01040 |
| MNDR | hsa-let-7c-5p | Neuroblastoma | MNDR-E-MI-01041 |
| MNDR | hsa-let-7c-5p | Barrett's adenocarcinoma | MNDR-E-MI-01042 |
| MNDR | hsa-let-7c-5p | Hodgkin lymphoma | MNDR-E-MI-01043 |
| MNDR | hsa-let-7c-5p | Burkitt lymphoma | MNDR-E-MI-01044 |
| MNDR | hsa-let-7c-5p | Tonsil cancer | MNDR-E-MI-01045 |
| MNDR | hsa-let-7c-5p | Neuromyelitis optica | MNDR-E-MI-01046 |
| MNDR | hsa-let-7c-5p | Acute myeloid leukemia | MNDR-E-MI-01047 |
| MNDR | hsa-let-7c-5p | Colorectal cancer | MNDR-E-MI-01048 |
| MNDR | hsa-let-7c-5p | Nasopharynx carcinoma | MNDR-E-MI-01049 |
| MNDR | hsa-let-7c-5p | Multiple myeloma | MNDR-E-MI-01050 |
| MNDR | hsa-let-7c-5p | Prostatic neoplasms | MNDR-E-MI-01051 |
| MNDR | hsa-let-7c-5p | Reperfusion injury | MNDR-E-MI-01052 |
| MNDR | hsa-let-7c-5p | Epstein-barr virus infections | MNDR-E-MI-01053 |
| MNDR | hsa-let-7c-5p | Barrett's carcinogenesis | MNDR-E-MI-01054 |
| MNDR | hsa-let-7c-5p | Breast cancer her3+ negative | MNDR-E-MI-01055 |
| MNDR | hsa-let-7c-5p | High grade dysplastic nodule | MNDR-E-MI-01056 |
| MNDR | hsa-let-7c-5p | Tubulovillous adenoma | MNDR-E-MI-01057 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC5 | Homo sapiens | RR00023746 |
TOP